Century Therapeutics (IPSC) Common Equity (2020 - 2026)
Century Therapeutics (IPSC) recorded Common Equity of $232.35 million in Q2 2026, up 10.7% from $209.9 million a year earlier but down 12.2% from the prior quarter.
Century Therapeutics (IPSC) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Century Therapeutics reported Common Equity of $158.94 million, down 1.5% from FY2024.
- Annual Common Equity has declined for four straight years.
- Across earlier years, Common Equity came in at $161.36 million in FY2024 (-12.7%), $184.75 million in FY2023 (-39.0%), $302.74 million in FY2022 (-23.6%) and $396.24 million in FY2021.
- Quarterly Common Equity has ranged from $158.94 million in Q4 2025 to $422.99 million in Q3 2021 over the past five years.
- On a year-over-year basis, Common Equity rose in three of the last eight quarters, with growth averaging 2.0%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 35.2% in Q1 2025, against a decline of 39.0% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $264.74 million (Q1 2026), $158.94 million (Q4 2025) and $176.35 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Century Therapeutics | 301.51 Mn | -202.86 Mn | - | 232.35 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 232.35 Mn |
| Mar 31, 2026 | 264.74 Mn |
| Dec 31, 2025 | 158.94 Mn |
| Sep 30, 2025 | 176.35 Mn |
| Jun 30, 2025 | 209.90 Mn |
| Mar 31, 2025 | 240.44 Mn |
| Dec 31, 2024 | 161.36 Mn |
| Sep 30, 2024 | 195.69 Mn |
| Jun 30, 2024 | 222.10 Mn |
| Mar 31, 2024 | 177.88 Mn |
| Dec 31, 2023 | 184.75 Mn |
| Sep 30, 2023 | 219.23 Mn |
| Jun 30, 2023 | 247.57 Mn |
| Mar 31, 2023 | 277.18 Mn |
| Dec 31, 2022 | 302.74 Mn |
| Sep 30, 2022 | 330.21 Mn |
| Jun 30, 2022 | 357.95 Mn |
| Mar 31, 2022 | 386.66 Mn |
| Dec 31, 2021 | 396.24 Mn |
| Sep 30, 2021 | 422.99 Mn |
Century Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IPSC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IPSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IPSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();